Core Viewpoint - The State Council of China has approved the "Open Innovation Development Plan for the Entire Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," aiming to enhance the biopharmaceutical sector's innovation and competitiveness on a global scale [2][5]. Group 1: Implementation Guidelines - The implementation of the plan should be guided by Xi Jinping's thoughts on socialism with Chinese characteristics for a new era, emphasizing high-quality development and a new development pattern [5]. - Jiangsu Provincial Government is tasked with formulating a special plan to ensure the objectives of the proposal are met, including risk prevention and regulatory collaboration [5]. Group 2: Strategic Importance - The biopharmaceutical industry is identified as a strategic emerging industry crucial for national security and public welfare [6]. - The plan emphasizes the integration of domestic and international resources, focusing on collaboration with research teams and innovation talents to enhance the industry [6]. Group 3: Innovation and Development - The government aims to build a robust platform for technology transfer and innovation, supporting the entire chain from basic research to industrial application [6]. - There is a focus on enhancing the service mechanisms for innovative drugs and medical devices, ensuring a supportive environment for high-quality development in the biopharmaceutical sector [6].
国务院批复:原则同意!
证券时报·2025-08-21 09:50